Arq (ARQ) Q1 2026 earnings review
PAC Stability Masks GAC Pauses and Tightening Liquidity
Arq delivered a mixed Q1 2026. Revenue grew 7% YoY to $29.1 million, driven by higher volumes in the foundational Powdered Activated Carbon (PAC) business. However, profitability retreated: Adjusted EBITDA fell 34% to $2.7 million and Net Income reversed to a $0.8 million loss, heavily impacted by an inventory revaluation charge and trailing costs from the paused Granular Activated Carbon (GAC) facility. With GAC production officially halted pending a strategic review due in Q3 2026, Arq is leaning entirely on its legacy PAC business and cost control to meet its reaffirmed FY26 guidance. Liquidity is becoming a point for monitoring as unrestricted cash dwindles.
🐂 Bull Case
The legacy PAC business continues to execute, driving 7% YoY revenue growth. April's plant turnaround was completed under budget, supporting management's claim that PAC is a consistently profitable platform.
Board and management ownership has increased to over 20% following recent open-market purchases, signaling strong internal conviction despite the GAC setbacks.
🐻 Bear Case
The GAC facility—originally touted as a massive high-margin growth driver—is completely paused. The ongoing strategic optimization review won't yield initial results until Q3 2026, pushing any meaningful GAC revenue into the distant future.
Of the $15.9M in total cash, $11.2M is restricted. This leaves just $4.7M in unrestricted cash against $30.2M in total debt, creating a tight liquidity environment for a company trying to fund a major engineering overhaul.
⚖️ Verdict: ⚪
Neutral. The legacy PAC business is successfully keeping the company afloat and management's insider buying is encouraging. However, the complete pause of the GAC growth story and tightening liquidity limit near-term upside until the Q3 2026 strategic review provides a clear path forward.
Key Themes
GAC Strategic Review Leaves a Growth Void
Arq’s transition into higher-margin Granular Activated Carbon (GAC) remains on hold. Management is working with independent engineering and equipment firms to resolve fundamental design flaws at the Red River facility. With initial findings not expected until Q3 2026, the company is evaluating alternatives like adding reactivation or acid washing capacity. This prolonged delay represents a severe execution failure relative to the 2025 narrative and leaves a massive void in the near-term growth story.
Unrestricted Cash and Debt Divergence
Liquidity requires immediate monitoring. While total cash appears stable at $15.9M, $11.2M of that is restricted. Unrestricted cash sits at just $4.7M (down from ~$6.5M at the end of 2025). Simultaneously, total debt crept up to $30.2M, driven primarily by $20.9M drawn on the MidCap revolving credit facility. The margin for error is shrinking while the company waits on the GAC review.
PAC Segment Doing the Heavy Lifting
The Powdered Activated Carbon (PAC) business continues to demonstrate Stable growth. The 7% YoY revenue increase to $29.1M was driven predominantly by volume enhancements. Furthermore, the successful, under-budget completion of the biennial plant turnaround (TAR) in April 2026 removes a near-term operational hurdle and should support margin normalization in subsequent quarters.
Gross Margins Pressured by Mix and Write-downs
Gross margin Reversing from 36.4% in 25Q1 to 34.2% in 26Q1 was driven by a negative product mix shift, a $0.8M non-cash inventory revaluation charge (tied to inventory produced in 2025), and lingering GAC carry-costs. Management noted that margins in January and February were 'exceptionally strong' prior to the March write-down, suggesting underlying profitability might be healthier than the headline number implies.
Corbin Asphalt Optionality Advancing
Testing of the Corbin wetcake feedstock with a leading U.S. asphalt company continues to progress. The material is demonstrating differentiated performance characteristics and is now advancing to small-scale in-field paving trials. If successful, this represents a significant alternative revenue stream that bypasses the troubled GAC activation process entirely.
Other KPIs
Decelerating sharply from $3.7 million in 25Q1. This 81% YoY drop perfectly illustrates the hard pause on GAC facility construction and commissioning. Capital is being preserved while the strategic review dictates the next move.
Accelerating from $6.1 million in 25Q1 (a 21% increase). Management attributed this to higher insurance, recruiting, and legal fees. In a period where GAC production is paused and cash is tight, rising corporate overhead is a headwind that contradicts the narrative of strict cost control.
Guidance
Stable. The reaffirmed midpoint of $122.5 million implies roughly 1.8% YoY growth compared to FY25's $120.3 million. Because GAC production is paused, this assumes the legacy PAC business will maintain its current volume and pricing momentum for the remainder of the year without any meaningful new capacity additions.
Accelerating. The reaffirmed midpoint of $18.5 million implies a massive 40% jump from FY25's $13.2 million. Given 26Q1 printed just $2.7M, the company needs to average over $5.2M per quarter for the rest of the year. This requires the absence of further inventory write-downs and a perfect realization of the 'normalized margins' management claims to have seen in Jan/Feb.
Key Questions
GAC Fix Capital Requirements
You are currently undergoing a strategic optimization review for the GAC facility with an engineering firm. Assuming a viable path forward is identified by Q3, what is the estimated range of capital required to execute the redesign, and how do you plan to fund it given current unrestricted cash levels?
Revolving Credit Facility Runway
With $20.9 million drawn on the MidCap revolving credit facility and unrestricted cash at $4.7 million, what is the total remaining borrowing capacity, and are there any covenants that might restrict operations over the next 12 months?
Asphalt Commercialization Timeline
The Corbin wetcake is moving to small in-field paving trials with a U.S. asphalt partner. What specific milestones need to be met in these trials to trigger commercial contract negotiations, and could we see revenue from this segment in 2027?